TipRanks
Go Ultimate55% OFF

Vivoryon Therapeutics AG (VVY) Cash flow

Vivoryon Therapeutics AG Cash Flow

NL:VVY's free cash flow for Q2 2026 was $-3.15M. For the 2026 fiscal year, NL:VVY's free cash flow was increased by $0.00 and operating cash flow was $-3.15M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
$ -8.46M$ -19.17M$ -21.54M$ -21.79M$ -11.26M
$ -6.00K$ 10.00M$ -10.51M$ -13.00K$ -28.00K
$ 4.71M$ -57.00K$ 24.16M$ 33.38M$ -827.00K
$ 5.62M$ 9.37M$ 18.56M$ 26.55M$ 14.66M
$ -8.46M$ -19.18M$ -22.05M$ -21.81M$ -11.29M

Currency in EUR

Vivoryon Therapeutics AG Cash Flow

-40M-20M020M40M60M201720182019202020212022202320242025OperatingInvestingFinancing